Sort
10,766 grants matching “checkpoint inhibitor”
Regulation of DNA double-strand break repair pathway choice
$120,750Wolf-Dietrich Heyer · University Of California At Davis · R01 · FY2024 · CA
Analysis of Loss of Function of MAD2 in Mammals
$120,668Washington University · K08 · FY2005 · CA
MOLECULAR CONTROL OF CELL GROWTH
$120,667University Of Washington · P50 · FY2000 · DK
Roles of DNA Ligase 1 in Mammalian DNA Metabolism
$120,593Alan E Tomkinson · University Of Maryland Baltimore · R01 · FY2011 · GM
Harnessing neutrophils to improve the efficacy of immune checkpoint inhibitors in breast cancer
$120,466Yang Gao · Baylor College Of Medicine · K99 · FY2024 · CA
Role of myeloid-derived suppressor cells in local and systemic immunosuppression in glioblastoma
$120,450Defne Bayik Watson · Cleveland Clinic Lerner Com-Cwru · K99 · FY2021 · CA
Role of myeloid-derived suppressor cells in local and systemic immunosuppression in glioblastoma
$120,450Defne Bayik Watson · Cleveland Clinic Lerner Com-Cwru · K99 · FY2022 · CA
Patient and Community Engagement Core
$120,279Hayley S. Thompson · Wayne State University · P20 · FY2022 · CA
Characterization of an inflammasome-unleashing approach to improve anti-PD-1 therapy in cancer
$120,219Marcelo Hill · Ardan Pharma S A S · R21 · FY2022 · CA
Molecular Targeting of the Survivin Pathway in Cancer
$120,098Yale University · R01 · FY2002 · CA
Immune exhaustion in perinatal HIV infection
$120,016Alka Khaitan · Indiana University Indianapolis · R21 · FY2021 · HD
INHIBITORS OF CYCLIN DEPENDENT KINASES
$119,986University Of South Florida · P01 · FY2000 · CA
Rational approaches to melanoma therapy
$119,969Meenhard Herlyn · Wistar Institute · U54 · FY2019 · CA
Rational approaches to melanoma therapy
$119,969Meenhard Herlyn · Wistar Institute · U54 · FY2019 · CA
Mentoring Patient Oriented Research in the Microbiome of Cancer and Stem Cell Transplant Patients
$119,884Andrew Y Koh · Ut Southwestern Medical Center · K24 · FY2021 · AI
Systematic Discovery and Characterization of Novel Cancer Anti-Phagocytic Mechanisms
$119,882Roarke Alexander Kamber · Stanford University · K99 · FY2022 · CA
Systematic Discovery and Characterization of Novel Cancer Anti-Phagocytic Mechanisms
$119,882Roarke Alexander Kamber · Stanford University · K99 · FY2023 · CA
Development of First-in-Class RIPK1 Degraders to Improve Cancer Immunotherapies
$119,583Jin Wang · Baylor College Of Medicine · R01 · FY2024 · CA
Mechanistic basis and therapeutic strategies for ARID1A mutation in ovarian cancer
$119,190Rugang Zhang · Wistar Institute · R01 · FY2022 · CA
Harnessing multi-modal and multi-omics data integration to decipher therapeutic response in non-small cell lung cancer
$119,172Yuanning Zheng · Stanford University · K99 · FY2025 · CA
Generation of novel murine B-cell lymphoma models using mosaic analysis by dual recombinase-mediated cassette exchange (MADR) to more closely resemble human B-cell lymphomas
$118,869Akil Merchant · Cedars-Sinai Medical Center · R01 · FY2024 · CA
Targeting the IL-33/ST2 Pathway in Colorectal Cancer Immunotherapy
$118,721Kevin Van Der Jeught · Indiana University Indianapolis · K99 · FY2022 · CA
Targeting the IL-33/ST2 Pathway in Colorectal Cancer Immunotherapy
$118,721Kevin Van Der Jeught · Indiana University Indianapolis · K99 · FY2021 · CA
Mentoring Patient Oriented Research in the Microbiome of Cancer and Stem Cell Transplant Patients
$118,387Andrew Y Koh · Ut Southwestern Medical Center · K24 · FY2022 · AI
Project 1: Targeting Metabolic Vulnerabilities in Lung Cancer
$118,034Ralph J Deberardinis · Ut Southwestern Medical Center · P50 · FY2023 · CA